These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3892667)

  • 1. [Low-molecular weight immunostimulants: cell membrane enzyme inhibitors].
    Lin ZB; Shi JP
    Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):115-20. PubMed ID: 3892667
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight immunomodifiers produced by microorganisms.
    Umezawa H; Ishizuka M
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low molecular weight immunomodulators produced by microorganisms].
    Ishizuka M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Biotechnol Bioeng; 1980; 22 Suppl 1():99-110. PubMed ID: 6968594
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
    Aoyagi T; Wada T; Ohuchi S; Kojima F; Nagai M; Harada S; Umezawa H
    J Pharmacobiodyn; 1984 Sep; 7(9):681-7. PubMed ID: 6527211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight immunomodifiers produced by micro-organisms.
    Umezawa H
    Biotechnol Genet Eng Rev; 1985; 3():255-73. PubMed ID: 2936359
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.
    Umezawa H
    Rev Infect Dis; 1984; 6(3):412-20. PubMed ID: 6234644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo actions of bestatin-related compounds in relation to their actions in vitro.
    Aoyagi T; Wada T; Ohuchi S; Kawamura K; Fukatsu S; Umezawa H
    Biochem Int; 1984 Nov; 9(5):643-50. PubMed ID: 6525200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors.
    Katragadda S; Talluri RS; Mitra AK
    Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low-molecular weight immunomodulators of microbial origin].
    Khurnova LM; Ivanitskaia LP
    Antibiot Khimioter; 1989 Oct; 34(10):786-92. PubMed ID: 2694992
    [No Abstract]   [Full Text] [Related]  

  • 12. Fundamental studies on bestatin: a small molecular microbial product enhancing immune response.
    Umezawa H
    Recent Results Cancer Res; 1981; 76():209-21. PubMed ID: 7232851
    [No Abstract]   [Full Text] [Related]  

  • 13. L-leucine and its analogue: specific inhibitors for S-benzyl-L-cysteine-p-nitroanilide-hydrolyzing enzyme in Escherichia coli B.
    Murata K; Iba Y; Inoue Y; Kimura A
    Biochem Biophys Res Commun; 1988 Jun; 153(2):767-72. PubMed ID: 3289539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the rectal aminopeptidase enzymatic activities of different species.
    Acartürk F; Parlatan ZI
    Pharmazie; 2003 Mar; 58(3):211-3. PubMed ID: 12685816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bestatin and muramyl-dipeptide on macrophage-bound aminopeptidase.
    Wachsmuth ED; Wüst B
    Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):563-8. PubMed ID: 7250904
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationships between enzyme inhibitors and function of mammalian cells.
    Aoyagi T; Umezawa H
    Acta Biol Med Ger; 1981; 40(10-11):1523-9. PubMed ID: 7044007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-molecular-weight immunocorrectors of natural origin].
    Ivanitskaia LP; Oparina ON; Stekhanova TN; Navashin SM
    Antibiot Med Biotekhnol; 1985 Feb; 30(2):131-8. PubMed ID: 3890722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diazo derivates of amino acids and peptides as possible antineoplastic chemotherapeutic agents. III. Activity on Galliera sarcoma of 2 N-diazoacetyl derivatives of glycine in comparison with azaserine and DON].
    BALDINI L; BRAMBILLA G; MATTIOLI F
    Boll Soc Ital Biol Sper; 1960 Nov; 36():1188-92. PubMed ID: 13686269
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation.
    Thielitz A; Bukowska A; Wolke C; Vetter R; Lendeckel U; Wrenger S; Hashimoto Y; Ansorge S; Gollnick H; Reinhold D
    Biochem Biophys Res Commun; 2004 Sep; 321(4):795-801. PubMed ID: 15358097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes.
    Gustafsson D; Antonsson T; Bylund R; Eriksson U; Gyzander E; Nilsson I; Elg M; Mattsson C; Deinum J; Pehrsson S; Karlsson O; Nilsson A; Sörensen H
    Thromb Haemost; 1998 Jan; 79(1):110-8. PubMed ID: 9459334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.